![](/img/cover-not-exists.png)
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples in a phase I study of mirvetuximab soravtansine, a FRα-targeting antibody-drug conjugate (ADC), in relapsed epithelial ovarian cancer patients
Martin, L.P., Konner, J., Moore, K.N., Seward, S.M., Matulonis, U.A., Perez, R.P., Zhou, Y., Ponte, J., Zhao, J., Ruiz-Soto, R., Birrer, M.J.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.089
Date:
June, 2017
File:
PDF, 99 KB
english, 2017